tedy bruschi throws muscle behind tobacco, stroke bills
.
.fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and
.yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital.
.ai-based software may help predict risk of dementia
.
.
yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital. .ai-based software may help predict risk of dementia .